Duration of diabetes and prevalence of diabetic retinopathy: Istanbul Diabetic Retinopathy Study-IDRS results 1

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 1, Issue 1, 2007, Pages 43-48

  Karadeniz, Z Sehnaz ^a   Yilmaz, M Temel ^b  

^a ISTANBUL BILIM UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Diabetic retinopathy; Duration of DM; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC); VISUAL SYSTEM EXAMINATION; VITRECTOMY;

EID: 34247877769     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2006.11.008     Document Type: Article

References (13)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Satman I., et al. Population-based study of diabetes and risk characteristics in Turkey. Results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25 (2002) 1551-1556
3. The State Institute of Statistics, Prime Ministry, Republic of Turkey. General Census 1997: Administrative Divisions. Ankara, State Institute of Statistics Pub. Co., 1999.
4. Gokcel A., Ozsahin A.K., Sezgin N., Karakose H., Ertorer M.E., Akbaba M., et al. High prevalence of diabetes in Adana, a southern province of Turkey. Diabetes Care 26 (2003) 3031-3034
5. Özturk Y., Aykut M., Kelestimur F., Gunay O., Cetinkaya F., Ceyhan O., et al. Prevalence of diabetes mellitus and affected factors in the district of Kayseri Health Group Area. Turk J Med Sci 30 (2000) 181-185
6. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 (1985) 1796-1806
7. Klein R., Klein B.E., Moss S.E., Davis M.D., and DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102 (1984) 520-526
8. Malone J., Morrison A.D., Pavan P.R., and Cuthbertson D.D. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the Diabetes Control and Complications Trial. Diabetes Care 24 (2001) 522-526
9. Klein R., Klein B.E., Moss S.E., Davis M.D., and DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102 (1984) 527-532
10. Brown J.B., Pedula K.L., and Summers K.H. Diabetic retinopathy. Contemporary prevalence in a well-controlled population. Diabetes Care 26 (2003) 2637-2642
11. Klein R., Klein B.E., Moss S.E., Davis M.D., and DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology 91 (1984) 1464-1474
12. M.T. Yi{dotless}lmaz, et al. Chronic complications in longterm type 1 and type 2 diabetic patients with comparable duration of diabetes and poor glycemic control: Turkish Diabetes Chronic Complications Trial-TUDIC Results 1. The World Congress on Controversies in Obesity, Diabetes and Hypertension 26-29 October 2006, Berlin, Germany. Program and Abstract Book D59, 2006.
13. Tas A., Bayraktar M.Z., Erdem U., Sobaci G., Durukan A.H., Karagul S., and Ucar M. Prevalence and risk factors for diabetic retinopathy in Turkey. Gulhane Tip Dergisi 47 (2005) 164-174